Effects of resveratrol on apoptosis in a rat model of vascular dementia

Experimental and Therapeutic Medicine

Volumn 7, Issue 4, 2014, Pages 843-848

  Sun, Zhi Kun ^a   Ma, Xing Rong ^b   Jia, Yan Jie ^b   Liu, Yan Ru ^b   Zhang, Jie Wen ^a   Zhang, Bo Ai ^b  

^a HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Apoptosis; Caspase 3; Poly(ADP ribose) polymerase; Resveratrol; Vascular dementia

Indexed keywords

CASPASE 3; PROTEIN BAX; PROTEIN BCL 2; RESVERATROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CAROTID ARTERY OBSTRUCTION; CONTROLLED STUDY; HIPPOCAMPUS; MEMORY DISORDER; MORRIS WATER MAZE TEST; MULTIINFARCT DEMENTIA; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; RAT; SPATIAL LEARNING; SPATIAL MEMORY; WESTERN BLOTTING;

EID: 84896711853     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.1542     Document Type: Article

References (34)

1. Wyllie AH: Apoptosis (the 1992 Frank Rose Memorial Lecture). Br J Cancer 67: 205-208, 1993.
2. Favaloro B, Allocati N, Graziano V, et al: Role of apoptosis in disease. Aging (Albany NY) 4: 330-349, 2012.
3. Jellinger KA: The enigma of vascular cognitive disorder and vascular dementia. Acta Neuropathol 113: 349-388, 2007.
4. Ni J, Ohta H, Matsumoto K and Watanabe H: Progressive cognitive impairment following chronic cerebral hypoperfusion induced by permanent occlusion of bilateral carotid arteries in rats. Brain Res 653: 231-236, 1994.
5. Kim SK, Cho KO and Kim SY: White matter damage and hippocampal neurodegeneration induced by permanent bilateral occlusion of common carotid artery in the rat: Comparison between Wistar and Sprague-Dawley strain. Korean J Physiol Pharmacol 12: 89-94, 2008.
6. Cechetti F, Worm PV, Pereira LO, et al: The modified 2VO ischemia protocol causes cognitive impairment similar to that induced by the standard method, but with a better survival rate. Braz J Med Biol Res 43: 1178-1183, 2010.
7. Gong X, Ma M, Fan X, et al: Down-regulation of IGF-1/IGF-1R in hippocampus of rats with vascular dementia. Neurosci Lett 513: 20-24, 2012.
8. Takaoka M: Resveratrol, a new phenolic compound from Veratrum grandiflorum. Nippon Kagaku Kaishi 60: 1090e100, 1939.
9. Shen M, Wu RX, Zhao L, et al: Resveratrol attenuates ischemia/reperfusion injury in neonatal cardiomyocytes and its underlying mechanism. PLoS One 7: e51223, 2012.
10. Ku CR, Lee HJ, Kim SK, et al: Resveratrol prevents streptozotocin-induced diabetes by inhibiting the apoptosis of pancreatic β-cell and the cleavage of poly (ADP-ribose) polymerase. Endocr J 59: 103-109, 2012.
11. Robb EL, Page MM, Wiens BE and Stuart JA: Molecular mechanisms of oxidative stress resistance induced by resveratrol: Specific and progressive induction of MnSOD. Biochem Biophys Res Commun 367: 406-412, 2008.
12. Bo S, Ciccone G, Castiglione A, et al: Anti-inflammatory and antioxidant effects of resveratrol in healthy smokers a randomized, double-blind, placebo-controlled, cross-over trial. Curr Med Chem 20: 1323-1331, 2013.
13. Athar M, Back JH, Kopelovich L, et al: Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms. Arch Biochem Biophys 486: 95-102, 2009.
14. Simão F, Matté A, Breier AC, et al: Resveratrol prevents global cerebral ischemia-induced decrease in lipid content. Neurol Res 35: 59-64, 2013.
15. Li Z, Pang L, Fang F, et al: Resveratrol attenuates brain damage in a rat model of focal cerebral ischemia via up-regulation of hippocampal Bcl-2. Brain Res 1450: 116-124, 2012.
16. Wu Z, Xu Q, Zhang L, et al: Protective effect of resveratrol against kainate-induced temporal lobe epilepsy in rats. Neurochem Res 34: 1393-1400, 2009.
17. Pasinetti GM, Wang J, Marambaud P, et al: Neuroprotective and metabolic effects of resveratrol: therapeutic implications for Huntington's disease and other neurodegenerative disorders. Exp Neurol 232: 1-6, 2011.
18. Khan MM, Ahmad A, Ishrat T, et al: Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease. Brain Res 1328: 139-151, 2010.
19. Li F, Gong Q, Dong H and Shi J: Resveratrol, a neuroprotective supplement for Alzheimer's disease. Curr Pharm Des 18: 27-33, 2012.
20. Guidance suggestions for the care and use of laboratory animals. The Ministry of Science and Technology of the People's Republic of China, Beijing, 2006.
21. Ma XR, Sun ZK, Liu YR, et al: Resveratrol improves cognition and reduces oxidative stress in rats with vascular dementia. Neural Regen Res 8: 2050-2059, 2013.
22. Sun ZK, Yang HQ, Pan J, et al: Protective effects of erythropoietin on tau phosphorylation induced by beta-amyloid. J Neurosci Res 86: 3018-3027, 2008.
23. Levine DA and Langa KM: Vascular cognitive impairment: disease mechanisms and therapeutic implications. Neurotherapeutics 8: 361-373, 2011.
24. Bennett S, Grant MM and Aldred S: Oxidative stress in vascular dementia and Alzheimer's disease: a common pathology. J Alzheimers Dis 17: 245-257, 2009.
25. Wang J, Zhang HY and Tang XC: Cholinergic deficiency involved in vascular dementia: possible mechanism and strategy of treatment. Acta Pharmacol Sin 30: 879-888, 2009.
26. Gustafsson AB and Gottlieb RA: Bcl-2 family members and apoptosis, taken to heart. Am J Physiol Cell Physiol 292: C45-C51, 2007.
27. Wolter KG, Hsu YT, Smith CL, et al: Movement of Bax from the cytosol to mitochondria during apoptosis. J Cell Biol 139: 1281-1292, 1997.
28. Clementi ME, Pezzotti M, Orsini F, et al: Alzheimer's amyloid beta-peptide (1-42) induces cell death in human neuroblastoma via bax/bcl-2 ratio increase: an intriguing role for methionine 35. Biochem Biophys Res Commun 342: 206-213, 2006.
29. Sun ZK, Yang HQ, Wang ZQ, et al: Erythropoietin prevents PC12 cells from beta-amyloid-induced apoptosis via PI3K/Akt pathway. Transl Neurodegener 1: 7, 2012.
30. Grütter MG: Caspases: key players in programmed cell death. Curr Opin Struct Biol 10: 649-655, 2000.
31. Lee MK, Kang SJ, Poncz M, et al: Resveratrol protects SH-SY5Y neuroblastoma cells from apoptosis induced by dopamine. Exp Mol Med 39: 376-384, 2007.
32. Alvarez-Gonzalez R, Spring H, Müller M and Bürkle A: Selective loss of poly(ADP-ribose) and the 85-kDa fragment of poly(ADP-ribose) polymerase in nucleoli during alkylation-induced apoptosis of HeLa cells. J Biol Chem 274: 32122-32126, 1999.
33. Lee DH, Park T and Kim HW: Induction of apoptosis by disturbing mitochondrial-membrane potential and cleaving PARP in Jurkat T cells through treatment with acetoxyscirpenol mycotoxins. Biol Pharm Bull 29: 648-654, 2006.
34. Oliver FJ, de la Rubia G, Rolli V, et al: Importance of poly(ADP-ribose) polymerase and its cleavage in apoptosis. Lesson from an uncleavable mutant. J Biol Chem 273: 33533-33539, 1998.